FDA Broke Its Own Rules to Approve Abortion Drugs: Doctor Analyzes Supreme Court’s First Abortion Case Since Roe v. Wade

The nation’s highest court will weigh in—around early 2024—on the FDA’s approval and regulation of the abortion pill mifepristone. Critics say the agency has loosened restrictions on the pill without considering its harmful effects on women.

We have Dr. Ingrid Skop, an OBGYN, with us to provide medical insight on the issue.